DeLuca Richard R. — SEC Form 4 filings
SEC reporting owner CIK 1421339. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-24 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 3 filings — 89,055 shares, $11,288,167 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 37,685 shares @ $120.92 ($4,557,025) in Merck & Co., Inc., filed 2026-02-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Merck & Co., Inc. (MRK) | EVP&Pres, Merck Animal Heallth | 11 | — | 9 legs · 89,055 sh · $11,288,167 | 15 |
Form 4 filings — DeLuca Richard R.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Merck & Co., Inc. (MRK) | Sale (S): 20,784 @ $130.43 · Sale (S): 7,410 @ $131.33 · Sale (S): 5,427 @ $132.35 · Sale (S): 11,099 @ $131.61 · Sale (S): 600 @ $132.04 | EDGAR |
| 2026-08-10 | 4 | Merck & Co., Inc. (MRK) | Sale (S): 805 @ $131.02 · Sale (S): 4,945 @ $130.23 · Sale (S): 300 @ $131.02 | EDGAR |
| 2026-05-07 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 11,931 (derivative) @ $0 · Grant/award (A): 34,924 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 2,518 @ $110.03 · Tax withholding (F): 1,241 @ $110.03 · Option exercise (M): 2,518 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Merck & Co., Inc. (MRK) | Sale (S): 37,685 @ $120.92 | EDGAR |
| 2026-01-28 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 12,264 @ $107.40 | EDGAR |
| 2025-05-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 7,555 (derivative) @ $0 · Grant/award (A): 34,390 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 25,438 @ $97.94 | EDGAR |
| 2024-05-06 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 27,126 @ $127.51 · Tax withholding (F): 13,360 @ $127.51 · Option exercise (M): 27,126 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 23,216 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 23,296 @ $119.43 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1421339 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →